[{"authors":["admin"],"categories":null,"content":"The various alleles of KRAS have known differences in their biochemical and signaling properties. Further, there are some correlations that suggest the allele has an effect on patient outcome.\nIn this analysis, we aim to compare the genetic landscapes of patient tumors with the common KRAS alleles.\n","date":1554595200,"expirydate":-62135596800,"kind":"taxonomy","lang":"en","lastmod":1554595200,"objectID":"2525497d367e79493fd32b198b28f040","permalink":"https://project-notebook-comutation.netlify.com/authors/admin/","publishdate":"0001-01-01T00:00:00Z","relpermalink":"/authors/admin/","section":"authors","summary":"The various alleles of KRAS have known differences in their biochemical and signaling properties. Further, there are some correlations that suggest the allele has an effect on patient outcome.\nIn this analysis, we aim to compare the genetic landscapes of patient tumors with the common KRAS alleles.","tags":null,"title":"Comutation of KRAS","type":"authors"},{"authors":null,"categories":null,"content":" Flexibility This feature can be used for publishing content such as:\n Online courses Project or software documentation Tutorials  The courses folder may be renamed. For example, we can rename it to docs for software/project documentation or tutorials for creating an online course.\nDelete tutorials To remove these pages, delete the courses folder and see below to delete the associated menu link.\nUpdate site menu After renaming or deleting the courses folder, you may wish to update any [[main]] menu links to it by editing your menu configuration at config/_default/menus.toml.\nFor example, if you delete this folder, you can remove the following from your menu configuration:\n[[main]] name = \u0026quot;Courses\u0026quot; url = \u0026quot;courses/\u0026quot; weight = 50  Or, if you are creating a software documentation site, you can rename the courses folder to docs and update the associated Courses menu configuration to:\n[[main]] name = \u0026quot;Docs\u0026quot; url = \u0026quot;docs/\u0026quot; weight = 50  Update the docs menu If you use the docs layout, note that the name of the menu in the front matter should be in the form [menu.X] where X is the folder name. Hence, if you rename the courses/example/ folder, you should also rename the menu definitions in the front matter of files within courses/example/ from [menu.example] to [menu.\u0026lt;NewFolderName\u0026gt;].\n","date":1536451200,"expirydate":-62135596800,"kind":"section","lang":"en","lastmod":1536451200,"objectID":"59c3ce8e202293146a8a934d37a4070b","permalink":"https://project-notebook-comutation.netlify.com/courses/example/","publishdate":"2018-09-09T00:00:00Z","relpermalink":"/courses/example/","section":"courses","summary":"Learn how to use Academic's docs layout for publishing online courses, software documentation, and tutorials.","tags":null,"title":"Overview","type":"docs"},{"authors":null,"categories":null,"content":" In this tutorial, I\u0026rsquo;ll share my top 10 tips for getting started with Academic:\nTip 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\nTip 2 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1557010800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1557010800,"objectID":"74533bae41439377bd30f645c4677a27","permalink":"https://project-notebook-comutation.netlify.com/courses/example/example1/","publishdate":"2019-05-05T00:00:00+01:00","relpermalink":"/courses/example/example1/","section":"courses","summary":"In this tutorial, I\u0026rsquo;ll share my top 10 tips for getting started with Academic:\nTip 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim.","tags":null,"title":"Example Page 1","type":"docs"},{"authors":null,"categories":null,"content":" Here are some more tips for getting started with Academic:\nTip 3 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\nTip 4 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1557010800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1557010800,"objectID":"1c2b5a11257c768c90d5050637d77d6a","permalink":"https://project-notebook-comutation.netlify.com/courses/example/example2/","publishdate":"2019-05-05T00:00:00+01:00","relpermalink":"/courses/example/example2/","section":"courses","summary":"Here are some more tips for getting started with Academic:\nTip 3 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus.","tags":null,"title":"Example Page 2","type":"docs"},{"authors":[],"categories":null,"content":" Click on the Slides button above to view the built-in slides feature.   Slides can be added in a few ways:\n Create slides using Academic\u0026rsquo;s Slides feature and link using slides parameter in the front matter of the talk file Upload an existing slide deck to static/ and link using url_slides parameter in the front matter of the talk file Embed your slides (e.g. Google Slides) or presentation video on this page using shortcodes.  Further talk details can easily be added to this page using Markdown and $\\rm \\LaTeX$ math code.\n","date":1906549200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1906549200,"objectID":"96344c08df50a1b693cc40432115cbe3","permalink":"https://project-notebook-comutation.netlify.com/talk/example/","publishdate":"2017-01-01T00:00:00Z","relpermalink":"/talk/example/","section":"talk","summary":"An example talk using Academic's Markdown slides feature.","tags":[],"title":"Example Talk","type":"talk"},{"authors":[],"categories":[],"content":" Preparing for CRUK presentation OP and I decided that I should just present the comutation project at today\u0026rsquo;s CRUK in-person meeting for the trainees. I made new versions of the genetic interaction networks with thicker edges to be more easily viewed on the screens.\n","date":1571702400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571702400,"objectID":"5ff920cc68b551dc9c5ccf3e650561e2","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-22/","publishdate":"2019-10-22T00:00:00Z","relpermalink":"/post/2019-10-22/","section":"post","summary":"Preparing for CRUK presentation OP and I decided that I should just present the comutation project at today\u0026rsquo;s CRUK in-person meeting for the trainees. I made new versions of the genetic interaction networks with thicker edges to be more easily viewed on the screens.","tags":[],"title":"2019-10-22","type":"post"},{"authors":[],"categories":[],"content":" Plots for specific types of genes Sources Transcription Factors\nI found a list of transcription factors from the TF2DNA Database. In the \u0026ldquo;Downloads\u0026rdquo; tab, I downloaded and unarchived the \u0026ldquo;TF matrix files\u0026rdquo;. The file names were taken as a list of transcription factors.\nI also used the ChEA_2106 gene set from Enrichr that pulled data from ChEA. The names of the gene sets contained transcription factors.\nHubs of the PPIN\nThe PPI_Hub_Proteins gene set was taken from Enrichr. The original data source was X2Kweb.\nKinases\nA list of kinases was acquired from the Kinase Enrichment Aalysis. The actual gene set was taken from Enrichr: KEA_2015.\nCell Cycle Regulators\nA list of cell-cycle regulators was taken from KEGG\u0026rsquo;s CELL_CYCLE gene set and Reactome\u0026rsquo;s CELL_CYCLE_MITOTIC gene set. The gene sets were taken from the MSigDB C2 list.\nThe preparation of each of these data sets was added to \u0026ldquo;munge/37_gene-list-preparation.R\u0026rdquo;.\n","date":1571616000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571616000,"objectID":"6ccad3897f34be257e7ffc56714949bf","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-21/","publishdate":"2019-10-21T00:00:00Z","relpermalink":"/post/2019-10-21/","section":"post","summary":"Plots for specific types of genes Sources Transcription Factors\nI found a list of transcription factors from the TF2DNA Database. In the \u0026ldquo;Downloads\u0026rdquo; tab, I downloaded and unarchived the \u0026ldquo;TF matrix files\u0026rdquo;. The file names were taken as a list of transcription factors.\nI also used the ChEA_2106 gene set from Enrichr that pulled data from ChEA. The names of the gene sets contained transcription factors.\nHubs of the PPIN","tags":[],"title":"2019-10-21","type":"post"},{"authors":[],"categories":[],"content":" Analysis of GSEA results (cont.) Yesterday, I was able to plot the results from the GSEA before the end of the day. The plots of the GSEA results don\u0026rsquo;t show anything terribly interesting. Dot-plots for each cancer are shown below. The gene set is displayed if it has a Normalized Enrichment Score (NES) of greater than 1.2 or less than -1.2 and a FDR-adjusted p-value of less than 0.20.\nCOAD LUAD PAAD Quick side note - I was curious about the relationship between the dependency on NF1 and KRAS allele in COAD cell lines. I therefore made a quick bar-plot showing this relationship in \u0026ldquo;src/90_10_NF1-depletion-COAD.R\u0026rdquo;. I\u0026rsquo;m not sure how to interpret the results, but will show KH.\nAnalysis of gene clusters from simple DepMap model. I looked for weakly connected components in the STRING PPI with the genes from each cluster of genes (with at least 4 nodes). To be clear, these are the same clusters as those shown in the heatmaps. Plots of all the components are in \u0026ldquo;graphs/10_15_linear-modeling-syn-let_ppi-subnetworks/\u0026ldquo;. Some are shown below.\nCOAD LUAD PAAD To-Do For synthetic lethal portion:\n specific plots for types of genes in the gene clusters  transcription factors hubs in PPI chromatin modifiers cell cycle   For comutation portion:\n plot p-value vs. cumulative number of genes for comutation and mutually exclusive plot p-value vs. number of events for co-mutation and mutual exclusivity  ","date":1571356800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571356800,"objectID":"be03b0b318660d64c099a3477ece56a7","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-18/","publishdate":"2019-10-18T00:00:00Z","relpermalink":"/post/2019-10-18/","section":"post","summary":"Analysis of GSEA results (cont.) Yesterday, I was able to plot the results from the GSEA before the end of the day. The plots of the GSEA results don\u0026rsquo;t show anything terribly interesting. Dot-plots for each cancer are shown below. The gene set is displayed if it has a Normalized Enrichment Score (NES) of greater than 1.2 or less than -1.2 and a FDR-adjusted p-value of less than 0.20.","tags":[],"title":"2019-10-18","type":"post"},{"authors":[],"categories":[],"content":" Analysis of GSEA results (cont.) I created dot-plots that show which gene sets are enriched for each allele in each cancer. They plots are available in \u0026ldquo;graphs/10_37_gsea-depmap-analysis/\u0026ldquo;.\nAfter looking at the results from just using the Hallmarks of Cancer gene set, I re-ran the GSEA to include the C2 Curated gene sets. This took way too long, though, so I remake the script to run as a job-array. For some reason, the 11th and final job (PAAD G12V) failed due to X11 errors. The log is shown below:\nslurmstepd: error: x11: job infos are invalid slurmstepd: error: spank: required plugin x11.so: user_init() failed with rc=- slurmstepd: error: spank_user failed. slurmstepd: error: Unable to return to working directory slurmstepd: error: job_manager exiting abnormally, rc = 4020  I just ran another job array with --array=11-11 and it worked.\nAll jobs were successfully running by 2:15 pm. From my notes the last time I ran GSEA suing Hallmark and C2 gene sets, this should take about 5 hours.\nDescribing genes in clusters of simple model results On 10\u0026frasl;14, I created the heatmaps in \u0026ldquo;graphs/10_10_linear-modeling-syn-let_pheatmaps\u0026rdquo;. The genes were cut into clusters by eye. I now want to use Enrichr to describe the genes in each cluster. This analysis was conducted in \u0026ldquo;src/10_10_linear-modeling-syn-let.R\u0026rdquo; in the section \u0026ldquo;Functional annotation of heatmap gene (row) clusters\u0026rdquo;. Tables of the outputs are available in \u0026ldquo;tables/10_10_linear-modeling-syn-let\u0026rdquo;; two tables are available, one with all of the significant hits (adjusted q-value \u0026lt; 0.20) and one with the top 5 from each data source for each gene cluster. This second table is also filtered for terms that are unique compared to the terms in the other clusters (ie. the term was only found for one cluster of genes). A third table was created after removing some of the more common terms: \u0026ldquo;gene-clusters-fxnal-enrichment_uncommon.tsv\u0026rdquo;.\n","date":1571270400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571270400,"objectID":"be2c3f9cc250dc80c6bff69759a65b87","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-17/","publishdate":"2019-10-17T00:00:00Z","relpermalink":"/post/2019-10-17/","section":"post","summary":"Analysis of GSEA results (cont.) I created dot-plots that show which gene sets are enriched for each allele in each cancer. They plots are available in \u0026ldquo;graphs/10_37_gsea-depmap-analysis/\u0026ldquo;.\nAfter looking at the results from just using the Hallmarks of Cancer gene set, I re-ran the GSEA to include the C2 Curated gene sets. This took way too long, though, so I remake the script to run as a job-array. For some reason, the 11th and final job (PAAD G12V) failed due to X11 errors.","tags":[],"title":"2019-10-17","type":"post"},{"authors":[],"categories":[],"content":" Analysis of GSEA results The code for this section is in \u0026ldquo;src/10_37_gsea-depmap-analysis.R\u0026rdquo;.\nPicking up from yesterday, I began by analyzing the GSEA results. I didn\u0026rsquo;t get very far before having to spend the rest of the day on other nonsense.\n","date":1571184000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571184000,"objectID":"5a45c6f949b443b3bb7df415e95867ba","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-16/","publishdate":"2019-10-16T00:00:00Z","relpermalink":"/post/2019-10-16/","section":"post","summary":"Analysis of GSEA results The code for this section is in \u0026ldquo;src/10_37_gsea-depmap-analysis.R\u0026rdquo;.\nPicking up from yesterday, I began by analyzing the GSEA results. I didn\u0026rsquo;t get very far before having to spend the rest of the day on other nonsense.","tags":[],"title":"2019-10-16","type":"post"},{"authors":[],"categories":[],"content":" GSEA of DepMap The script \u0026ldquo;src/10_30_gsea-depmap-preparation.R\u0026rdquo; prepares the input data for GSEA.\nThe bash script \u0026ldquo;src/10_35_gsea-depmap.sh\u0026rdquo; runs all of the GSEA tests.\nData preparation GSEA User Guide\nGSEA Data Formats\nExpression Data Set\nIt is a tab-delimted file (extension .txt) with the following format:\n   NAME DESCRIPTION sample1 sample2 sample3     gene1 na      gene2 na       For this analysis, the DepMap gene effect values are used in place of RNA expression.\nPhenotype Labels\nA normal text file with extension .cls and the following format:\n{numberOfSamples} {numberOfClasses} 1 # {class0Name} {class1Name} 0 0 0 0 0 0 1 1 1 1 1  Gene Sets\nI downloaded gene sets from MSigDB to \u0026ldquo;data/gsea/\u0026rdquo; and added the directory to the ignore list.\nRunning GSEA The following command runs the script. It first removes all of the previous results.\nsbatch src/10_35_gsea-depmap.sh  To-Do Tomorrow Tomorrow, I need to parse the results of the GSEA and address the first portion of the To-Do from yesterday:\n Tomorrow, I would like to figure out a way of partitioning the allele-specific synthetic lethality hits so I can do a functional enrichment test. Perhaps, I can use the groups from the heatmap clusters.\n ","date":1571097600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571097600,"objectID":"4f7111b1e5b24178fd64970539d57cb7","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-15/","publishdate":"2019-10-15T00:00:00Z","relpermalink":"/post/2019-10-15/","section":"post","summary":"GSEA of DepMap The script \u0026ldquo;src/10_30_gsea-depmap-preparation.R\u0026rdquo; prepares the input data for GSEA.\nThe bash script \u0026ldquo;src/10_35_gsea-depmap.sh\u0026rdquo; runs all of the GSEA tests.\nData preparation GSEA User Guide\nGSEA Data Formats\nExpression Data Set\nIt is a tab-delimted file (extension .txt) with the following format:\n   NAME DESCRIPTION sample1 sample2 sample3     gene1 na      gene2 na       For this analysis, the DepMap gene effect values are used in place of RNA expression.","tags":[],"title":"2019-10-15","type":"post"},{"authors":[],"categories":[],"content":" Summarizing current status of comutation analysis Before continuing, it seemed reasonable to summarize the current status of the comutation and mutual exclusivity analysis. This summary is located in Comutation and Mutual Exclusivity.\nI changed the thresholds for the comutation and mutual exclusivity results in \u0026ldquo;src/20_35_rc-fisher-comparison.R\u0026rdquo; to be more strict because the numbers of interactions detected seemed unbelievably high. I then re-ran all downstream analyses.\nI fixed a bug in the dot-plots of the Enrichr results. If there were no 0 values, then the minimum number would be set to zero for the alpha and point size. Now, the minimum values for the alpha and point size are 0.1 and 1, respectively, if there are no zero values.\nFinishing off the summary on the comutation analysis, I turned my attention back to the synthetic lethality portion of the project.\nContinuing with simple linear model of allele-specific synthetic lethality I created heatmaps of the signficiant results from the simple model of allele-specific synthetic lethality. They are intended to give an over view of the number of genes and also the intensity of the differences found.\nCOAD LUAD PAAD To-Do Tomorrow Tomorrow, I would like to figure out a way of partitioning the allele-specific synthetic lethality hits so I can do a functional enrichment test. Perhaps, I can use the groups from the heatmap clusters.\nI also want to run the GSEA/GSVA/ssGSEA for the synthetic lethality. I need to look back at what these methods do before deciding on which to start with.\n","date":1571011200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1571011200,"objectID":"23b8b68a0da387315b0da514dc951acf","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-14/","publishdate":"2019-10-14T00:00:00Z","relpermalink":"/post/2019-10-14/","section":"post","summary":"Summarizing current status of comutation analysis Before continuing, it seemed reasonable to summarize the current status of the comutation and mutual exclusivity analysis. This summary is located in Comutation and Mutual Exclusivity.\nI changed the thresholds for the comutation and mutual exclusivity results in \u0026ldquo;src/20_35_rc-fisher-comparison.R\u0026rdquo; to be more strict because the numbers of interactions detected seemed unbelievably high. I then re-ran all downstream analyses.\nI fixed a bug in the dot-plots of the Enrichr results.","tags":[],"title":"2019-10-14","type":"post"},{"authors":[],"categories":[],"content":" Bug fix At the end of yesterday, I noticed the following bug:\n There is a bug where not all of the interactions are being included. For example, BRAF is only connected to G13D in the KEGG-specific interaction network.\n After a bit of digging I found that the BRAF mutations were being labeled as significant, but were filtered out by the filter(num_mut_per_cancer \u0026gt;= 3) in \u0026ldquo;src/20_35_rc-fisher-comparison.R\u0026rdquo;. The problem was that the \u0026ldquo;num_mut_per_cancer\u0026rdquo; column was NA for all of the alleles except for one, G13D.\nTherefore, I adjusted \u0026ldquo;munge/30_rc-test_results-prep.R\u0026rdquo; to fix this bug. The problem was with a data frame merging by, among other columns, KRAS allele. However, since there are 0 comutation events between BRAF and some of the alleles, the values were NA not zero.\nA test was added to make sure this is fixed (available in \u0026ldquo;tests/test-30_rc-test_results-prep.R\u0026rdquo;).\nAll of the dependent files were re-run and the figures should now be accurate.\nFunctional Enrichment (cont.) The results from the functional enrichment were written to Excel and TSV files for independent analysis. The data frame was also cached.\nI tried multiple plotting modalities to help with parsing the results. The attempts included a network and bar-plots, but finally settled on a dot-plot for each data source. The x and y-axes are the KRAS allele and enriched terms, respectively. The size and color of the dots indicate the \u0026ldquo;strength\u0026rdquo; of the association by representing the p-value and number of genes with genetic interactions in the gene set, respectively. I made one plot for each data source and cancer combination. A few examples are shown below.\nCOAD The following plot is of the Kinase Enrichment Analysis (KEA) gene sets in COAD.\nThe plot below is showing the enriched gene sets made up of the protein-protein interaction networks of transcription factors.\nLUAD The following plot shows the pathways (from the PANTHER data base) enriched in the genetic interactions of KRAS alleles in LUAD.\nMM The following plot shows the pathways (from the PANTHER database) enriched in the genetic interactions of KRAS alleles in MM.\nIn addition, the following shows the same, but using the BioCarta database instead.\nKEA The following plot is of the Kinase Enrichment Analysis (KEA) gene sets in PAAD.\nThe following plot shows the pathways (from the PANTHER database) enriched in the genetic interactions of KRAS alleles in LUAD.\nIn addition, the following shows the same, but using the WikiPathways database instead.\n","date":1570838400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570838400,"objectID":"c950eb58b7b5a743f68403872429e5ea","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-12/","publishdate":"2019-10-12T00:00:00Z","relpermalink":"/post/2019-10-12/","section":"post","summary":"Bug fix At the end of yesterday, I noticed the following bug:\n There is a bug where not all of the interactions are being included. For example, BRAF is only connected to G13D in the KEGG-specific interaction network.\n After a bit of digging I found that the BRAF mutations were being labeled as significant, but were filtered out by the filter(num_mut_per_cancer \u0026gt;= 3) in \u0026ldquo;src/20_35_rc-fisher-comparison.R\u0026rdquo;. The problem was that the \u0026ldquo;num_mut_per_cancer\u0026rdquo; column was NA for all of the alleles except for one, G13D.","tags":[],"title":"2019-10-12","type":"post"},{"authors":[],"categories":[],"content":" Analysis of hits from genetic interaction tests (cont.) I began by fixing the UpSet plots such that they now include all sets and intersections. (The updated images are shown in yesterday\u0026rsquo;s notebook.)\nA priori gene lists For the figure, I see the \u0026ldquo;cloud\u0026rdquo; (ie. high-level) network adjacent to the UpSet plots to describe that the comutation patterns are distinct between the alleles. Then, the next two logical questions would be:\n Are there any important/notable genes in there? Are any specific functions enriched for the alleles?  I began this follow up with the first question. As noted in yesterday\u0026rsquo;s notebook, I have gathered the following gene lists:\n the following KEGG gene sets (from MSigDB) (a full list is available at the end of this notebook):  apoptosis, cell-cycle ERBB signaling pathway Hedgehog signaling pathway MAPK signaling pathway mTOR signaling pathway Notch signaling pathway p53 signaling pathway VEGF signaling pathway WNT signaling pathway  the interactors with WT KRAS from Kovalski et al., 2019 and the COSMIC Cancer Gene Consensus  The analysis was conducted in \u0026ldquo;src/20_43_apriori-lists-genetic-interactions.R\u0026rdquo;.\nDuring the analysis, I had to go back to \u0026ldquo;munge/30_rc-test_results-prep.R\u0026rdquo; and \u0026ldquo;src/20_35_rc-fisher-comparison.R\u0026rdquo; to fix some filtering mistakes. Their effects on the results were minor.\nThe resulting plots are shown below. For some of the LUAD and PAAD, I present separate plots for each source of gene list to keep the plot legible.\nCOAD LUAD KEGG pathways\nPhysical Interactors\nCGC Genes\nMM PAAD KEGG pathways\nPhysical Interactors\nCGC Genes\nA few comments  There are some genes that comutate with one allele and are mutually exclusive with another. This is something to look into. There are some obvious stand-outs in terms of how \u0026ldquo;strong\u0026rdquo; (low p-value) the interaction is. Again, these are likely worth further investigation.  Functional Enrichment Instead of using specific gene lists chosen for a priori reasons, I used a statistical tool to identify biological functions that are enriched in the list of genes identified to have a genetic interaction with a KRAS allele.\nErncihR The first attempt used the Enrichr (Chen et al., 2013) tool available through a R API using the \u0026lsquo;enrichR\u0026rsquo; package (link to the web API).\nThe following data bases were used:\n \u0026ldquo;BioCarta_2016\u0026rdquo;, \u0026ldquo;GO_Biological_Process_2018\u0026rdquo;, \u0026ldquo;KEA_2015\u0026rdquo;, \u0026ldquo;KEGG_2019_Human\u0026rdquo;, \u0026ldquo;LINCS_L1000_Kinase_Perturbations_down\u0026rdquo;, \u0026ldquo;LINCS_L1000_Kinase_Perturbations_up\u0026rdquo;, \u0026ldquo;Panther_2016\u0026rdquo;, \u0026ldquo;PPI_Hub_Proteins\u0026rdquo;, \u0026ldquo;Reactome_2016\u0026rdquo;, \u0026ldquo;Transcription_Factor_PPIs\u0026rdquo;, \u0026ldquo;WikiPathways_2019_Human\u0026rdquo;  A complete list can be found using the following command in R.\nsort(enrichR::listEnrichrDbs()$libraryName)  The results were filtered by adjusted p-value \u0026lt; 0.20 and at least 2 genes in the gene set. The filtered tables were written to \u0026ldquo;tables/20_45_fxnal-enrich-genetic-interactions\u0026rdquo;.\nTODO\nThere is a bug where not all of the interactions are being included. For example, BRAF is only connected to G13D in the KEGG-specific interaction network.\nFull List of KEGG Genesets GLYCOLYSIS_GLUCONEOGENESIS, CITRATE_CYCLE_TCA_CYCLE, PENTOSE_PHOSPHATE_PATHWAY, PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS, FRUCTOSE_AND_MANNOSE_METABOLISM, GALACTOSE_METABOLISM, ASCORBATE_AND_ALDARATE_METABOLISM, FATTY_ACID_METABOLISM, STEROID_BIOSYNTHESIS, PRIMARY_BILE_ACID_BIOSYNTHESIS, STEROID_HORMONE_BIOSYNTHESIS, OXIDATIVE_PHOSPHORYLATION, PURINE_METABOLISM, PYRIMIDINE_METABOLISM, ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM, GLYCINE_SERINE_AND_THREONINE_METABOLISM, CYSTEINE_AND_METHIONINE_METABOLISM, VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION, VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS, LYSINE_DEGRADATION, ARGININE_AND_PROLINE_METABOLISM, HISTIDINE_METABOLISM, TYROSINE_METABOLISM, PHENYLALANINE_METABOLISM, TRYPTOPHAN_METABOLISM, BETA_ALANINE_METABOLISM, TAURINE_AND_HYPOTAURINE_METABOLISM, SELENOAMINO_ACID_METABOLISM, GLUTATHIONE_METABOLISM, STARCH_AND_SUCROSE_METABOLISM, N_GLYCAN_BIOSYNTHESIS, OTHER_GLYCAN_DEGRADATION, O_GLYCAN_BIOSYNTHESIS, AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM, GLYCOSAMINOGLYCAN_DEGRADATION, GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE, GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE, GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE, GLYCEROLIPID_METABOLISM, INOSITOL_PHOSPHATE_METABOLISM, GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS, GLYCEROPHOSPHOLIPID_METABOLISM, ETHER_LIPID_METABOLISM, ARACHIDONIC_ACID_METABOLISM, LINOLEIC_ACID_METABOLISM, ALPHA_LINOLENIC_ACID_METABOLISM, SPHINGOLIPID_METABOLISM, GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES, GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES, GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES, PYRUVATE_METABOLISM, GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM, PROPANOATE_METABOLISM, BUTANOATE_METABOLISM, ONE_CARBON_POOL_BY_FOLATE, RIBOFLAVIN_METABOLISM, NICOTINATE_AND_NICOTINAMIDE_METABOLISM, PANTOTHENATE_AND_COA_BIOSYNTHESIS, FOLATE_BIOSYNTHESIS, RETINOL_METABOLISM, PORPHYRIN_AND_CHLOROPHYLL_METABOLISM, TERPENOID_BACKBONE_BIOSYNTHESIS, LIMONENE_AND_PINENE_DEGRADATION, NITROGEN_METABOLISM, SULFUR_METABOLISM, AMINOACYL_TRNA_BIOSYNTHESIS, METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450, DRUG_METABOLISM_CYTOCHROME_P450, DRUG_METABOLISM_OTHER_ENZYMES, BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS, ABC_TRANSPORTERS, RIBOSOME, RNA_DEGRADATION, RNA_POLYMERASE, BASAL_TRANSCRIPTION_FACTORS, DNA_REPLICATION, SPLICEOSOME, PROTEASOME, PROTEIN_EXPORT, PPAR_SIGNALING_PATHWAY, BASE_EXCISION_REPAIR, NUCLEOTIDE_EXCISION_REPAIR, MISMATCH_REPAIR, HOMOLOGOUS_RECOMBINATION, NON_HOMOLOGOUS_END_JOINING, MAPK_SIGNALING_PATHWAY, ERBB_SIGNALING_PATHWAY, CALCIUM_SIGNALING_PATHWAY, CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION, CHEMOKINE_SIGNALING_PATHWAY, PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM, NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION, CELL_CYCLE, OOCYTE_MEIOSIS, P53_SIGNALING_PATHWAY, UBIQUITIN_MEDIATED_PROTEOLYSIS, SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT, REGULATION_OF_AUTOPHAGY, LYSOSOME, ENDOCYTOSIS, PEROXISOME, MTOR_SIGNALING_PATHWAY, APOPTOSIS, CARDIAC_MUSCLE_CONTRACTION, VASCULAR_SMOOTH_MUSCLE_CONTRACTION, WNT_SIGNALING_PATHWAY, DORSO_VENTRAL_AXIS_FORMATION, NOTCH_SIGNALING_PATHWAY, HEDGEHOG_SIGNALING_PATHWAY, TGF_BETA_SIGNALING_PATHWAY, AXON_GUIDANCE, VEGF_SIGNALING_PATHWAY, FOCAL_ADHESION, ECM_RECEPTOR_INTERACTION, CELL_ADHESION_MOLECULES_CAMS, ADHERENS_JUNCTION, TIGHT_JUNCTION, GAP_JUNCTION, COMPLEMENT_AND_COAGULATION_CASCADES, ANTIGEN_PROCESSING_AND_PRESENTATION, RENIN_ANGIOTENSIN_SYSTEM, TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY, NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY, RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY, CYTOSOLIC_DNA_SENSING_PATHWAY, JAK_STAT_SIGNALING_PATHWAY, HEMATOPOIETIC_CELL_LINEAGE, NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY, T_CELL_RECEPTOR_SIGNALING_PATHWAY, B_CELL_RECEPTOR_SIGNALING_PATHWAY, FC_EPSILON_RI_SIGNALING_PATHWAY, FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS, LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION, INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION, CIRCADIAN_RHYTHM_MAMMAL, LONG_TERM_POTENTIATION, NEUROTROPHIN_SIGNALING_PATHWAY, LONG_TERM_DEPRESSION, OLFACTORY_TRANSDUCTION, TASTE_TRANSDUCTION, REGULATION_OF_ACTIN_CYTOSKELETON, INSULIN_SIGNALING_PATHWAY, GNRH_SIGNALING_PATHWAY, PROGESTERONE_MEDIATED_OOCYTE_MATURATION, MELANOGENESIS, ADIPOCYTOKINE_SIGNALING_PATHWAY, TYPE_II_DIABETES_MELLITUS, TYPE_I_DIABETES_MELLITUS, MATURITY_ONSET_DIABETES_OF_THE_YOUNG, ALDOSTERONE_REGULATED_SODIUM_REABSORPTION, VASOPRESSIN_REGULATED_WATER_REABSORPTION, PROXIMAL_TUBULE_BICARBONATE_RECLAMATION, ALZHEIMERS_DISEASE, PARKINSONS_DISEASE, AMYOTROPHIC_LATERAL_SCLEROSIS_ALS, HUNTINGTONS_DISEASE, PRION_DISEASES, VIBRIO_CHOLERAE_INFECTION, EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION, PATHOGENIC_ESCHERICHIA_COLI_INFECTION, LEISHMANIA_INFECTION, PATHWAYS_IN_CANCER, COLORECTAL_CANCER, RENAL_CELL_CARCINOMA, PANCREATIC_CANCER, ENDOMETRIAL_CANCER, GLIOMA, PROSTATE_CANCER, THYROID_CANCER, BASAL_CELL_CARCINOMA, MELANOMA, BLADDER_CANCER, CHRONIC_MYELOID_LEUKEMIA, ACUTE_MYELOID_LEUKEMIA, SMALL_CELL_LUNG_CANCER, NON_SMALL_CELL_LUNG_CANCER, ASTHMA, AUTOIMMUNE_THYROID_DISEASE, SYSTEMIC_LUPUS_ERYTHEMATOSUS, ALLOGRAFT_REJECTION, GRAFT_VERSUS_HOST_DISEASE, PRIMARY_IMMUNODEFICIENCY, HYPERTROPHIC_CARDIOMYOPATHY_HCM, ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC, DILATED_CARDIOMYOPATHY, VIRAL_MYOCARDITIS\n","date":1570752000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570752000,"objectID":"6e7a6b7c2fd2d64c8c0d5eb91b08a402","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-11/","publishdate":"2019-10-11T00:00:00Z","relpermalink":"/post/2019-10-11/","section":"post","summary":"Analysis of hits from genetic interaction tests (cont.) I began by fixing the UpSet plots such that they now include all sets and intersections. (The updated images are shown in yesterday\u0026rsquo;s notebook.)\nA priori gene lists For the figure, I see the \u0026ldquo;cloud\u0026rdquo; (ie. high-level) network adjacent to the UpSet plots to describe that the comutation patterns are distinct between the alleles. Then, the next two logical questions would be:","tags":[],"title":"2019-10-11","type":"post"},{"authors":[],"categories":[],"content":" Comparing results from Fisher\u0026rsquo;s test and RC-test Looking at GM\u0026rsquo;s figure 3, I\u0026rsquo;m not sure how he has such a sparse figure for PAAD. From his results, there should be a lot of genes for KRAS G12D (\u0026gt; 800) at even a p-value cut-off of 0.01.\nFrom yesterday\u0026rsquo;s conclusion to use the Fisher\u0026rsquo;s exact test for comutation and the RC-test for mutual exclusivity, I created a combined data frame with both of these data for future use: genetic_interaction_df.\nAnalysis of hits from genetic interaction tests This analysis was conducted in \u0026ldquo;src/20_40_genetic-interaction-hits.R\u0026rdquo;.\nFor a first pass, I just identified genes that might be of interest by using curated lists:\n the following KEGG gene sets (from MSigDB): the interactors with WT KRAS from Kovalski et al., 2019 and the COSMIC Cancer Gene Consensus  Gene list preparation These files were all parsed and cached in \u0026ldquo;munge/37_gene-list-preparation.R\u0026rdquo;\nThe BioID data was available in an Excel spreadsheet with merged cells. Therefore, it was difficult to read in and prepare as-is. I manually removed the annoying cells in a new file \u0026ldquo;Kovalski-et-al-2019_BioID_REFORMATTED.xlsx\u0026rdquo;\nThe resulting files are:\n cosmic_cgc_df kegg_geneset_df kras_interactors_bioid_df genes_of_interest_df (a collation of the genes and their sources)  Overlap Looking at each cancer, there is a good amount of overlap between the genetic interactions and the a priori genes of interest.\n   Cancer num. genes     COAD 108   LUAD 218   MM 15   PAAD 295    To see these genes in relation to each other, I imported the STRING pathway and selected just the proteins found in the overlap.\nThe STRING data base was downloaded on 2019-09-20 and all the original files are in my data base directory \u0026ldquo;/n/no_backup2/dbmi/park/jc604/databases/networks/STRING/\u0026ldquo;. The preparation was done in \u0026ldquo;munge/40_STRING-network-preparation.R\u0026rdquo;.\nDuring this analysis, I decided to stop because the computation was taking too long and the output was unlikely to be interesting. I will revisit this analysis, but I first want to deal with the zoomed-out view of comparing the results of the alleles.\nHigh-level genetic interaction figures This analysis was conducted in \u0026ldquo;src/20_40_highlivel-genetic-interactions.R\u0026rdquo;.\nI began work on the genetic interaction figures with the Fisher\u0026rsquo;s exact test used for comutation and the RC-test used for mutual exclusivity. I employed UpSet plots (using UpSetR) to visualize the overlap of the comutation and mutual exclusive interactions. As Joe stated, the UpSet plot is essentially a higher-dimensional Venn diagram.\n(The following plots do not have titles because there is no parameter for adding one in UpSetR\u0026hellip;)\nCOAD Comutation\nMutually Exclusive\nLUAD Comutation\nMutually Exclusive\nMM Comutation\nMutually Exclusive\nPAAD Comutation\nMutually Exclusive\nI also re-created the genetic interaction network plots. This time, however, I did not include the names all of genes, but instead use the plot to demonstrate higher-level trends.\nCOAD Many of the alleles are connected by shared mutually-exclusive interactions and have their own \u0026ldquo;clouds\u0026rdquo; of comutation interactions. This can be seen very clearly between G12D and G12V.\nInterestingly, Q61K and Q61L seem to be quite similar.\nLUAD There is a lot of overlap of mutually exclusive interactions between G12C and G12V. These alleles are both driven by smoke, but I can\u0026rsquo;t think of an explanation why this would drive mutual exclusivity.\nMM The allele-specific genetic interactions are very sparse, possibly speaking to the large distribution of KRAS alleles found in the diease. This may indicate that the allele is not as impactful in MM as it is in COAD, LUAD, and PAAD.\nThere are a few mutually exclusive partners shared by a few alleles.\nPAAD There are a lot of significant interactions here. Interestingly (worryingly?) I report here many(!) more comutation interactions than GM does in his figure even though we are use the same results. Even if I reduce the p-value cutoff to 0.01, I report at least an order of magnitude more interactions that GM. I definitely need to get to the bottom of this\u0026hellip;\nFinal notes  I need to look into why there is such a large discrepancy between my and GM\u0026rsquo;s figures, especially for PAAD. It appears that there are some genes that comutate with one allele and are mutually exclusive with another. These may be interesting to look further into. Not all of the alleles are appearing in the UpSet plots. I have added a note to the code to fix this.  ","date":1570665600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570665600,"objectID":"5696a3ff02198fe382c1b93ddce94f02","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-10/","publishdate":"2019-10-10T00:00:00Z","relpermalink":"/post/2019-10-10/","section":"post","summary":"Comparing results from Fisher\u0026rsquo;s test and RC-test Looking at GM\u0026rsquo;s figure 3, I\u0026rsquo;m not sure how he has such a sparse figure for PAAD. From his results, there should be a lot of genes for KRAS G12D (\u0026gt; 800) at even a p-value cut-off of 0.01.\nFrom yesterday\u0026rsquo;s conclusion to use the Fisher\u0026rsquo;s exact test for comutation and the RC-test for mutual exclusivity, I created a combined data frame with both of these data for future use: genetic_interaction_df.","tags":[],"title":"2019-10-10","type":"post"},{"authors":[""],"categories":[],"content":" Synthetic Lethality Synthetic lethality refers to a genetic interaction whereby one mutation sensitizes an organism to another normally-benign mutation. This overlaps with \u0026ldquo;dependency\u0026rdquo; whereby the first mutation pushes the organism into a state of reliance on specific functions. Blocking (by mutation or inhibition) this function would cause the mutant organism to die, but not effect the wild-type organisms. Thus, a current goal of much of cancer research is focussed on finding synthetic lethal interactions with common oncogenes.\nAllele-specific synthetic lethality The goal of this portion of the Comutation project is to identify synthetic lethal interactions with specific KRAS alleles. From a theory point-of-view, these interactions would provide information on the differences between the alleles. From a therapeutics point-of-view, the identification of allele-specific interactions could be used to further personalize treatment strategies.\nData For this analysis, we used the Cancer Dependency Mapping (DepMap) data. In this ongoing study, the cell lines from the Cancer Cell Line Encyclopedia (CCLE) were analyzed in a genome-wide, CRISPR-Cas9, loss-of-function screen whereby each gene was systemically knocked-out and the loss of growth of the cell line was measured. Thankfully, many omics data are available for the cell lines, including RNA expression, mutations, and CNA.\n","date":1570618710,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570618710,"objectID":"7b062ec3f65d8e9795bb59850a7c7902","permalink":"https://project-notebook-comutation.netlify.com/project/allele-specific-synthetic-lethality/","publishdate":"2019-10-09T06:58:30-04:00","relpermalink":"/project/allele-specific-synthetic-lethality/","section":"project","summary":"Synthetic Lethality Synthetic lethality refers to a genetic interaction whereby one mutation sensitizes an organism to another normally-benign mutation. This overlaps with \u0026ldquo;dependency\u0026rdquo; whereby the first mutation pushes the organism into a state of reliance on specific functions. Blocking (by mutation or inhibition) this function would cause the mutant organism to die, but not effect the wild-type organisms. Thus, a current goal of much of cancer research is focussed on finding synthetic lethal interactions with common oncogenes.","tags":["synthetic lethality","KRAS"],"title":"KRAS Allele-Specific Synthetic Lethality","type":"project"},{"authors":[""],"categories":[],"content":" Overview Our hypothesis is that genes with comutate or be mutually exclusive with specific KRAS alleles depending on the biological properties of the allele. Comutation would occur when the additional mutation enhances the growth phenotype of the tumor. And example of this would be KRAS, TP53, and CDKN2A in PAAD. On the other hand, another gene and KRAS would mutate in a mutually exclusive pattern because doing so leads to a reduction in growth. A very strong example of this is the mutually exclusive activation mutations in BRAF and KRAS.\nAnalysis Comutation To study comutation, we conducted a one-sided Fisher\u0026rsquo;s exact test for association between each KRAS allele and all other genes.\nMutual Exclusivity The Row-Column test for mutual exclusivity (the \u0026ldquo;RC-test\u0026rdquo;) was developed by the Raphael Lab in 2016 and described in A weighted exact test for mutually exclusive mutations in cancer (Leiserson et al., 2016). The software supplied with the paper searched for any groups of genes demonstrating mutually exclusive relationships, but took far too long to compute over all of our samples. Therefore, I implemented the RC-test in my own R package (in dev, WeXT) and used Snakemake to orchestrate the runs on O2 in parallel. Again, the test was run between each KRAS allele and all other genes.\nHigh-level visualization To provide a higher-level visualization of the results, the genetic interactions were displayed as a network. These are meant to be interpreted as \u0026ldquo;clouds\u0026rdquo; where the density of the cloud provides an idea of the number of interactions.\nI also created UpSet plots to show the size and overlap of the sets. These can be interpreted as high-dimensional Venn diagrams.\nAnalysis of biological properties of the genetic interactors I used a priori gene lists to identify any genes of interest that have detectable genetic interactions with the KRAS alleles. The lists were notable KEGG pathways, the physical interactors of KRAS from a BioID experiment conducted in Kovalski et al., 2019, and the COSMIC Cancer Gene Consensus.\nI also used Enrichr (Chen et al., 2013) to identify gene sets enriched in the interactors for each KRAS allele.\nResults The following figure shows the number of genes with a genetic interaction that was detected for each KRAS allele. For comutation, there had to be at least 3 comutation events to be included. For mutual exclusivity, the other gene had to be mutated at least 10 times in the cancer. For both tests, a p-value of 0.01 was used for the declaration of statistical significance.\nThe plot shows that the number of detectable interactions increases with the number of samples, as expected.\nThe rest of the summary is subdivided by cancer.\nCOAD\nLUAD\nMM\nPAAD\nCOAD Below are the high-level visualizations of the genetic interactions. The alleles tend to be connected by mutual exclusive interactions (instead of comutation interactions). Each allele also has their own set of comutation and mutually exclusive interactors.\nThe network below shows all of the interactions with genes in the a priori lists. As expected, BRAF is strongly mutually exclusive with many of the alleles and PIK3CA and APC comutate with several alleles, too. Surprisingly, G12D and G13D are mutually exclusive with TP53. A146T has two interesting comutation interactions with PORCN and MAP3K1. G12V has a very strong comutation interaction with SMAD4. G12C has a strong comutation interaction with RAPGEF2. G12S (bottom left) has a comutation interaction with SMAD3.\nThe KEGG pathway gene set was very informative. Notably, G13D was enriched for the mTOR pathway, including RICTOR as shown in the above network. The genes with interactions with G12D are enriched in adhesion pathways (\u0026ldquo;Regulation of actin cytoskeleton\u0026rdquo; and \u0026ldquo;Focal adhesion\u0026rdquo;, \u0026ldquo;Leukocyte TEM\u0026rdquo;), possibly linked to the enrichment for the Rap1 signaling pathway. Many of the alleles have interactions with genes involved in ERBB signaling.\nAlso of note, but not shown graphically here, the physical interactors of SMAD2, a transcription factor, were found to be enriched in the G12D genetic interactors by two different gene sets.\nLUAD Below are the high-level visualizations of the genetic interactions. The alleles tend to be connected by mutual exclusive interactions (instead of comutation interactions). This is especially true for G12C, G12V, and G12D. Each allele also has their own set of comutation and mutually exclusive interactors. There are many genes that are mutually exclusive with one allele and comutate with another.\nThe genetic interaction networks with genes in the a prior lists are divided in to the KEGG pathways (top) and the CGC (bottom). There are very strong mutually exclusive relationships between EGFR, BRAF, and TP53, as expected. Also, there is a strong comutation interaction between G12C and STK11. In the CGC network, it appears that G12C is mutually exclusive with CTNNB1 ($\\beta$-catenin). G12C also is mutually exclusive with three different genes involved in voltage-gated calcium channels. G12C is mutually exclusive with JAG2 and comutates with NOTCH1 suggesting a special relationship with the Notch signaling pathway. The three alleles linked to the smoking mutational signature, G12A/C/V, and Q61L have strong comutation interactions with ATM. There are several comutation interactions that are unexpected, namely between G12D and G12R with NKX2-1, Homeobox protein Nkx-2.1. This gene is a \u0026ldquo;transcription factor that binds and activates the promoter of thyroid specific genes,\u0026rdquo; and \u0026ldquo;may play a role in lung development and surfactant homeostasis,\u0026rdquo; (UniProt P43699). Another interesting relationship is that KRAP1 comutates with G13D and G13C, but is mutually exclusive with G12V and G12C. This could indicate an codon-specific property of hyperactivated KRAS in LUAD.\nThe results of an enrichment analysis using a gene set of PPI hub proteins are shown first. The physical interactors with $\\beta$-catenin and SMARC4 are enriched in the interactors of G12C. The interactors of PKC-$\\alpha$ (gene PKRCA) are enriched in G12V genetic interactions. PKC-$\\alpha$ is a \u0026ldquo;calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP,\u0026rdquo; (UniProt P17252).\nThe results of an enrichment analysis using a gene set of GO Biological Processes are shown below. G12A seems to have an enrichment for genes involved in P53-mediated cell cycle arrest. There are several Ras-related processes enriched in the G12C interactors.\nMM Below are the high-level visualizations of the genetic interactions. There were not very many hits for multiple myeloma and very little overlap of the interacting genes between KRAS alleles.\nBelow is the network of genetic interactions for genes in the a priori lists. There is a detectable mutually exclusive interaction between Q61H and BRAF, though it is documented that MM can be highly multi-clonal. Therefore, there are often subpopulations of KRAS mutants and BRAF mutants within a single disease. This is likely true for KRAS and other genes, making the interpretation of these results difficult.\nThere was little evidence for functional enrichment in these genes.\nPAAD Below are the high-level visualizations of the genetic interactions. There were many allele-specific comutation and mutually exclusive interactions detected in PAAD. Further or more strict thresholds may be applied in future analyses to reduce false-positives.\nBelow are the interaction networks for genes in the a priori gene lists.\nThe first is of genes found to directly interact with KRAS in the CGC. Along with BRAF, there were some unexpected genes found to be mutually exclusive with multiple alleles. Interestingly, RNF43 was foound to be mutually exclusive with G12R, but comutates with G12D. RNF43 is \u0026ldquo;E3 ubiquitin-protein ligase that acts as a negative regulator of the Wnt signaling pathway by mediating the \u0026hellip; degradation of \u0026hellip; Frizzled,\u0026rdquo; (UniProt Q68DV7). In addition, TP53 is mutually exclusive with G12V, but comutates with Q61H and G12D. This is interesting because of the general perception that both KRAS and TP53 mutations are quintessential steps of PAAD progression. SMARCA4 is strongly mutually exclusive with G12R.\nThe following is the network of genetic interactions with genes found to directly interact with KRAS. One of the strongest interactions is between G12V and ATP2B1, the protein product of which helps regulate intracellular calcium levels at the plasma membrane. Another strong interaction is the mutually exclusive relationship between G12D and NF1. The obvious mechanism to propose for this is the same as that for BRAF.\nThe next genetic network is of the genes from select KEGG pathways. An interaction that really pops out is the strong comutation between Q61K and MAP3K13 and compared to the mutually exclusive relationships between G12V and G12R and the same gene. A similar case of conflicting interactions is found with MAP2K4 where it comutates with Q61R and is mutually exclusive with G12D. G12D strongly comutates with TGFBR2 - this transmembrane S/T-kinase activates SMAD2/4 when it binds with the cytokines TGFB1/2/3 (UniProt P37173). JAG2 is found to comutate with G12R, yet is mutually exclusive with G12V.\nTwo gene sets with interesting results from the enrichment analysis are shown below. The top is of kinases whose substrates are overrepresented in the associations, and the bottom is of Panther pathways.\nThere are a lot of substrates for the kinase PKA C-$\\alpha$ (gene PRKACA) that have genetic interactions with G12D and G12V. This kinase is involved in many cellular functions including Hedgehog and NF$\\kappa$B signaling. The substrates of Akt1 are also overrepresented in the genes with genetic interactions with G12D.\nMany genes involved in Wnt signaling have genetic interactions with several alleles. Genes of the EGFR pathway have many interactions with G12D.\n","date":1570618689,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570618689,"objectID":"696696eb53b5eb218f5299cab72e8b92","permalink":"https://project-notebook-comutation.netlify.com/project/comutation-and-mutual-exclusivity/","publishdate":"2019-10-09T06:58:09-04:00","relpermalink":"/project/comutation-and-mutual-exclusivity/","section":"project","summary":"Testing for genetic interactions in human tumor samples based on their mutational patterns.","tags":["comutation","KRAS"],"title":"Comutation and Mutual Exclusivity","type":"project"},{"authors":[],"categories":[],"content":" Finish preparing RC-test results The final step was to merge the actual mutation numbers for each gene to the results from the RC-test.\nThese new values were used to update the plots made in \u0026ldquo;20_30_rc-test-results-analysis.R\u0026rdquo; (also shown in the notebook for 2019-10-07).\nGeneral scope of results Below is the number of significant interactions (p-value \u0026lt; 0.05 and at-least 3 events) per cancer found by the RC-test.\nThe plot below separates the bars by the type of interaction.\nInteraction networks Munge Fisher\u0026rsquo;s test for comutation results To compare against the RC test, I prepared the results from GM\u0026rsquo;s test for comutation (a Fisher\u0026rsquo;s exact test). The file \u0026ldquo;OR_fisher_multiTest_Aug2019.txt\u0026rdquo; was copied from the shared DropBox to \u0026ldquo;data/fisher-comutation\u0026rdquo;. It is prepared for further use in \u0026ldquo;munge/35_comutation-results-gm.R\u0026rdquo;.\nFor future reference, here is the 2x2 table that GM used for the columns n00 through n11:\n     KRAS        WT mut   gene WT n00 n01    mut n10 n11    Comparing results from Fisher\u0026rsquo;s test and RC-test This comparison was conducted in \u0026ldquo;src/20_35_rc-fisher-comparison.R\u0026rdquo;.\nThe first plot just shows the gross number of genes found to be signficant for each test, split by comutation and mutual exclusivity.\nThis plot shows a large discrepancy between the two tests: the RC-test was more sensitive when testing for mutual exclusivity while the opposite was true for the Fisher\u0026rsquo;s exact test. On closer inspection, it seemed that the Fisher\u0026rsquo;s test out-performed the RC-test for detecting comutation because we were able to use the panel data. The panel data could not be used for the RC-test because the test accounts for the total number of mutations in the sample.\nFrom these results, I propose that we use the Fisher\u0026rsquo;s test for comutation and RC-test for mutual exclusivity. This makes sense in so far as the RC-test was originally made for detecting mutual exclusivity and is equivalent (when comparing two genes) to the Fisher\u0026rsquo;s exact test for comutation as it approaches the limit. Therefore, it is an approximation where it is not needed because we can just do the Fisher\u0026rsquo;s exact test.\n","date":1570579200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570579200,"objectID":"27c3960d547db1a919c17442340ca601","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-09/","publishdate":"2019-10-09T00:00:00Z","relpermalink":"/post/2019-10-09/","section":"post","summary":"Finish preparing RC-test results The final step was to merge the actual mutation numbers for each gene to the results from the RC-test.\nThese new values were used to update the plots made in \u0026ldquo;20_30_rc-test-results-analysis.R\u0026rdquo; (also shown in the notebook for 2019-10-07).\nGeneral scope of results Below is the number of significant interactions (p-value \u0026lt; 0.05 and at-least 3 events) per cancer found by the RC-test.\nThe plot below separates the bars by the type of interaction.","tags":[],"title":"2019-10-09","type":"post"},{"authors":[],"categories":[],"content":" Plan for analysis I did not have time to work on this project today, but I found time in the evening to think about how I want to progress.\nRC-test results analysis Tomorrow, I will focus on moving forward with analyzing the results from the RC-test. I need to merge in the number of mutation events in order to remove the genetic interactions that do not meet a low standard. For comutation, there should be at least 2 co-mutation events. For mutual exclusivity, the other gene should be mutated in at least 0.01% of all the cancer\u0026rsquo;s samples. This will remove a lot of mutually exclusive events that are caused by the mutation just being very rare.\nI will then compare the results to those from the Fisher\u0026rsquo;s exact test:\n How many genes are shared by each allele between the two analyses (Venn diagram for each allele) For the shared genes, how do the p-values compare (scatter plot with x and y-axis as p-value from each analysis; a line for $y = x$)  Finally, I will look for interesting results in the significant genes. This will start with highlight CGC genes. Also those found from the BioID screen of KRAS and KRAS mutants. Lastly, I will use WebGestalt, EnrichR, or PANTHER (PMID: 23868073 for updated overview) to find functional patterns in the gene lists.\nFor the paper, I see the text reading something to the effect of, \u0026ldquo;X tended to comutate with KRAS A and B but no interaction was detected for KRAS C nor D,\u0026rdquo; for individual CGC genes. Also, for any enriched biological processes, the text would look something like, \u0026ldquo;There was an enrichment for function Y in the genes found to comutate with KRAS E, potentially suggesting \u0026hellip;\u0026rdquo;\nHere is where I will stop until completing the synthetic lethal analysis. Once I have completed that to a satisfactory degree, I will look for overlap between the hits from each analysis.\nAllele-specific synthetic lethality So far, I have only completed the simplest possible analysis to find allele-specific synthetic lethality. Briefly, I removed the genes that could be explained by their RNA expression. Then, I conducted an ANOVA and pair-wise comparisons to find differences in lethality between cells with the various KRAS alleles, including WT. Some of the most interesting results can be found on yesterday\u0026rsquo;s notebook, and all plots are available in \u0026ldquo;graphs/10_10_linear-modeling-syn-let_bosplots/\u0026ldquo;.\nI want a way of visualizing all of these results (especially for the meeting with KH and PJP). The obvious way is to produce a heatmap of patient vs. gene with the genes that were found to have a significant difference. Then, I could show specific box-plots for genes of interest (CGC, KRAS interactors from BioID screen, specific KEGG pathways).\nAnother approach could be to look for enriched biological processes/pathways. To this end, we could employ an analysis similar to GSEA. We could run GSEA as one KRAS allele against all other cell lines or just the KRAS WT cell lines. I will also look into GSVA and ssGSEA, two popular variants of GSEA.\nA quick analysis that could be very fruitful is to conduct a PCA on the gene-space and see if the cell lines cluster by KRAS allele. If they do, that would lend credence to our claim that the KRAS allele is important. (It may be useful to plot the first few PCs using tSNE or UMAP.) If there appear to be clusters, then some sort of clustering (K-means, hierarchical clustering, DBSCAN, spectral clustering, etc.) could be used to make the claim concrete. Even just a difference between KRAS and WT would be supportive of our claim.\nLASSO of KRAS WT vs mutant starting with all genes as covariates. Use the genes with non-trivial parameters in a random forest classifier or niave bayes classifier to predict the KRAS allele (including WT).\n","date":1570492800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570492800,"objectID":"2baef37321172e099be496affdf38b48","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-08/","publishdate":"2019-10-08T00:00:00Z","relpermalink":"/post/2019-10-08/","section":"post","summary":"Plan for analysis I did not have time to work on this project today, but I found time in the evening to think about how I want to progress.\nRC-test results analysis Tomorrow, I will focus on moving forward with analyzing the results from the RC-test. I need to merge in the number of mutation events in order to remove the genetic interactions that do not meet a low standard.","tags":[],"title":"2019-10-08","type":"post"},{"authors":[],"categories":[],"content":" RC Co-mutation test Introduction A while back, I thought of using the RC-test for co-mutation and mutual exclusivity from A weighted exact test for mutually exclusive mutations in cancer (Leiserson et al., 2016) in place of the Fisher\u0026rsquo;s exact test that Giorgio had employed. The benefit of this test is that it accounts for the number of mutations per sample in its estimate of significance. The main draw back is that it is permutation-based, and thus very slow.\nI was able to write a Snakemake script to run the test for all cancers and KRAS alleles. It has finally completed all of the tests and I will now port it over to this project. To move forward with the analysis, I will just port over the results and begin parsing. I will go back and move the files for running the analysis over in the future. For now, it is located on O2 at the following URL: \u0026ldquo;/n/data2/bidmc/medicine/haigis/Cook/KrasComutation/FinalAnalyses/RC_comutation_2/\u0026rdquo;\nMunging I copied the directory of the output of the RC-test into the data dir.\nmkdir data/rc-test-results cp -r ../KrasComutation/FinalAnalyses/RC_comutation_2/output/* data/rc-test-results  These files are automatically loaded into R by running load.project(). I combined all of the information into a single data frame, rc_test_results, in the munging script \u0026ldquo;30_rc-test_results-prep.R\u0026rdquo;. Here, I also extracted the non-KRAS gene from the gene_set column. The raw files were added to the list of raw data to ignore in \u0026ldquo;config/global.dcf\u0026rdquo;.\nAnalyzing RC-test results General scope of results Below is the number of significant interactions (p-value \u0026lt; 0.05 and at-least 3 events) per cancer found by the RC-test.\nThe plot below separates the bars by the type of interaction.\nInteraction networks Moving the RC-test directory to this project I got this far and decided that moving forward with any analysis would require a lot of the information from the RC-test directory. Therefore, I stopped and ported it over. The following are the steps I took.\nMoving input, intermediate, and output data mkdir data/rc-test mkdir data/rc-test/input data/rc-test/intermediate data/rc-test/output  cp ../KrasComutation/FinalAnalyses/RC_comutation_2/input/* data/rc-test/input/ cp ../KrasComutation/FinalAnalyses/RC_comutation_2/intermediate/* data/rc-test/intermediate/ cp -r ../KrasComutation/FinalAnalyses/RC_comutation_2/output/* data/rc-test/output/ cp -r ../KrasComutation/FinalAnalyses/RC_comutation_2/permuted_graphs data/rc-test/  Moving example DAG image cp ../KrasComutation/FinalAnalyses/RC_comutation_2/images/dag.pdf graphs/20_20_rc-test_Snakefile/  Moving scripts cp ../KrasComutation/FinalAnalyses/RC_comutation_2/Snakefile src/20_20_rc-test_Snakefile cp ../KrasComutation/FinalAnalyses/RC_comutation_2/snakemake_scripts/* src/ cp ../KrasComutation/FinalAnalyses/RC_comutation_2/prepare_input_tables.R src/ cp ../KrasComutation/FinalAnalyses/RC_comutation_2/generate_sm_output_names.R src cp ../KrasComutation/FinalAnalyses/RC_comutation_2/cluster.json config/  The snakemake scripts were renamed. I did my best to update the Snakefile for the new directory, but real testing will be required to truly find out. A bash script was created to run the Snakemake file on O2, \u0026ldquo;20_21_run-rc-test-snakemake.sh\u0026rdquo;.\nMunging cancer data from Giorgio Melloni GM used a deeply-nested data structure for the cancer data. His format is not conducive to my coding style (and is very large). I created another munging script to prepare this data, \u0026ldquo;20_prepare-cancer-data.R\u0026rdquo;. The files from GM were copied from the old directory to \u0026ldquo;data/cancer-data/\u0026rdquo;.\n","date":1570406400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570406400,"objectID":"6a36a2edc754968882819e9fb2e4d5a0","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-07/","publishdate":"2019-10-07T00:00:00Z","relpermalink":"/post/2019-10-07/","section":"post","summary":"RC Co-mutation test Introduction A while back, I thought of using the RC-test for co-mutation and mutual exclusivity from A weighted exact test for mutually exclusive mutations in cancer (Leiserson et al., 2016) in place of the Fisher\u0026rsquo;s exact test that Giorgio had employed. The benefit of this test is that it accounts for the number of mutations per sample in its estimate of significance. The main draw back is that it is permutation-based, and thus very slow.","tags":[],"title":"2019-10-07","type":"post"},{"authors":[],"categories":[],"content":" Modeling KRAS allele-specific synthetic lethality (cont.) Continuing from yesterday, I worked on plotting the box-plots of genes found to be significantly depleted in KRAS mutants. There was a bug in \u0026lsquo;ggpubr\u0026rsquo; that installing the dev. version from GitHub fixed. I also ignored cell lines of LUAD with KRAS G13D mutations because they are irrelevant to patients.\nDepletion box-plots were made for the genes that passed the following criteria:\n The linear model of depletion effect and RNA expression was non-significant (p-value \u0026lt; 0.01). The ANOVA across all alleles was significant at a relatively stringent cut-off (p-value \u0026lt; 0.01). There was at least one significant pairwise comparison (FDR adj. p-value \u0026lt; 0.05)  All of the box-plots are in \u0026ldquo;graphs/10_10_linear-modeling-syn-let_boxplots/\u0026ldquo;. Below are some of the more interesting genes to pop out of the analysis.\nCOAD From UniProt ARI5B_HUMAN:\n Transcription coactivator that binds to the 5\u0026rsquo;-AATA[CT]-3\u0026rsquo; core sequence and plays a key role in adipogenesis and liver development. Acts by forming a complex with phosphorylated PHF2, which mediates demethylation at Lys-336, leading to target the PHF2-ARID5B complex to target promoters, where PHF2 mediates demethylation of dimethylated \u0026lsquo;Lys-9\u0026rsquo; of histone H3 (H3K9me2), followed by transcription activation of target genes\u0026hellip; Required for adipogenesis: regulates triglyceride metabolism in adipocytes by regulating expression of adipogenic genes. Overexpression leads to induction of smooth muscle marker genes, suggesting that it may also act as a regulator of smooth muscle cell differentiation and proliferation.\n From UniProt SRP09_HUMAN:\n Signal-recognition-particle assembly has a crucial role in targeting secretory proteins to the rough endoplasmic reticulum membrane. SRP9 together with SRP14 and the Alu portion of the SRP RNA, constitutes the elongation arrest domain of SRP. The complex of SRP9 and SRP14 is required for SRP RNA binding.\n LUAD From UniProt: STABP_HUMAN:\n Zinc metalloprotease that specifically cleaves \u0026lsquo;Lys-63\u0026rsquo;-linked polyubiquitin chains. Does not cleave \u0026lsquo;Lys-48\u0026rsquo;-linked polyubiquitin chains (By similarity). Plays a role in signal transduction for cell growth and MYC induction mediated by IL-2 and GM-CSF. Potentiates BMP (bone morphogenetic protein) signaling by antagonizing the inhibitory action of SMAD6 and SMAD7. Has a key role in regulation of cell surface receptor-mediated endocytosis and ubiquitin-dependent sorting of receptors to lysosomes. Endosomal localization of STAMBP is required for efficient EGFR degradation but not for its internalization (By similarity). Involved in the negative regulation of PI3K-AKT-mTOR and RAS-MAP signaling pathways.\n PAAD From UniProt: EGLN2_HUMAN:\n Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A. Also hydroxylates HIF2A\u0026hellip; Hydroxylated HIFs are then targeted for proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Under hypoxic conditions, the hydroxylation reaction is attenuated allowing HIFs to escape degradation resulting in their translocation to the nucleus, heterodimerization with HIF1B, and increased expression of hypoxy-inducible genes. EGLN2 is involved in regulating hypoxia tolerance and apoptosis in cardiac and skeletal muscle. Also regulates susceptibility to normoxic oxidative neuronal death. Links oxygen sensing to cell cycle and primary cilia formation by hydroxylating the critical centrosome component CEP192 which promotes its ubiquitination and subsequent proteasomal degradation. Hydroxylates IKBKB, mediating NF-kappaB activation in hypoxic conditions. Target proteins are preferentially recognized via a LXXLAP motif.\n From UniProt JUN_HUMAN:\n Transcription factor that recognizes and binds to the enhancer heptamer motif 5\u0026rsquo;-TGA[CG]TCA-3\u0026rsquo; (PubMed:10995748, PubMed:22083952). Promotes activity of NR5A1 when phosphorylated by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation (PubMed:17210646). Involved in activated KRAS-mediated transcriptional activation of USP28 in colorectal cancer (CRC) cells (PubMed:24623306). Binds to the USP28 promoter in colorectal cancer (CRC) cells (PubMed:24623306).\n Notes for tomorrow There were some genes that have way too many data points (see example below). I need to figure out what is causing this. My guess is that they are related genes and the gene names are being truncated by get_hugo_from_depmap_ids().\n","date":1570233600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570233600,"objectID":"ea7875c62cda805f9bc86ce095e301be","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-05/","publishdate":"2019-10-05T00:00:00Z","relpermalink":"/post/2019-10-05/","section":"post","summary":"Modeling KRAS allele-specific synthetic lethality (cont.) Continuing from yesterday, I worked on plotting the box-plots of genes found to be significantly depleted in KRAS mutants. There was a bug in \u0026lsquo;ggpubr\u0026rsquo; that installing the dev. version from GitHub fixed. I also ignored cell lines of LUAD with KRAS G13D mutations because they are irrelevant to patients.\nDepletion box-plots were made for the genes that passed the following criteria:\n The linear model of depletion effect and RNA expression was non-significant (p-value \u0026lt; 0.","tags":[],"title":"2019-10-05","type":"post"},{"authors":[],"categories":[],"content":" I have outlined an estimate for a time-line for the rest of the project to the first submission. It is located on the homepage of this website.\nModeling KRAS allele-specific synthetic lethality I began by trying to use a linear model, regressing on KRAS allele, RNA expression of the tarter, and whether the target was altered (CN amplification or coding mutation). I then used a step-wise AIC feature selection method to optimize the model for each gene. I ran into a problem, however, in how to declare the intercept of the model. Originally, I had the WT allele set as the intercept, but this is irrelevant for the RNA expression feature. To further complicate matters, PAAD does not have enough WT KRAS cell lines, so the intercept was set to KRAS G12D. This is obviously not what we want to model\nTherefore, I have changed to a two-step process. First, I regress the depletion effect on the RNA expression of the target gene. The genes with a significant model (p \u0026lt; 0.01) are discorded. The second step is to run an ANOVA and conduct pair-wise T-tests.\nProblem: While doing this, I realized that LUAD only has enough cell lines (at least 3) for WT and G12C, but not G12V like there was before. I found that the problem was I specifically selected cell lines by their disease subtype containing \u0026ldquo;Adenocarcinoma\u0026rdquo;. I changed the selection criteria for the lung cell lines to linear_subtype == \u0026quot;lung_NSC\u0026quot;. The problem was resolved.\n","date":1570147200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570147200,"objectID":"4ac960d960edd24c502df0820a02f646","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-04/","publishdate":"2019-10-04T00:00:00Z","relpermalink":"/post/2019-10-04/","section":"post","summary":"I have outlined an estimate for a time-line for the rest of the project to the first submission. It is located on the homepage of this website.\nModeling KRAS allele-specific synthetic lethality I began by trying to use a linear model, regressing on KRAS allele, RNA expression of the tarter, and whether the target was altered (CN amplification or coding mutation). I then used a step-wise AIC feature selection method to optimize the model for each gene.","tags":[],"title":"2019-10-04","type":"post"},{"authors":[],"categories":[],"content":" Analysis to remove genes that can confidently be removed (cont.) I finished up making confidently_unexpressed_genes (cached). I then returned to the munging script for preparing the model data and removed the genes were are confident are not expressed in the normal or tumor.\nLinear modeling allele-specificity Linear Model 1 The first model I tried was a simple linear model (using lm()) of the following form.\ngene_effect ~ allele + is_altered + rna_scaled  It attempts the use the KRAS allele, A step-wise feature selection AIC-based method was applied to each model.\nOther thoughts\nLatent variable analysis of DepMap data. Regress on the depletion effect of each gene for a patient. The latent variables are signaling pathway. Results show which pathways are most important. But will I just pull out the essential pathways? The goal of the DepMap analysis is to find lethals.\nSo instead for each gene, have features be mutational status, RNA expression, CNA of other genes (each feature of each gene linked to each other). Latent variables are pathways.\n","date":1570060800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1570060800,"objectID":"a3d4fa2b5190c664162009a18319708a","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-03/","publishdate":"2019-10-03T00:00:00Z","relpermalink":"/post/2019-10-03/","section":"post","summary":"Analysis to remove genes that can confidently be removed (cont.) I finished up making confidently_unexpressed_genes (cached). I then returned to the munging script for preparing the model data and removed the genes were are confident are not expressed in the normal or tumor.\nLinear modeling allele-specificity Linear Model 1 The first model I tried was a simple linear model (using lm()) of the following form.\ngene_effect ~ allele + is_altered + rna_scaled  It attempts the use the KRAS allele, A step-wise feature selection AIC-based method was applied to each model.","tags":[],"title":"2019-10-03","type":"post"},{"authors":[],"categories":[],"content":" Analysis to remove genes that can confidently be removed This was originally done in the old analysis structure, so can mainly be copied over to this directory system.\nThe HPA and GTEx data were moved from \u0026ldquo;/n/no_backup2/dbmi/park/jc604/databases/tissue_gene_expression/\u0026rdquo; to \u0026ldquo;data/tissue-gene-expression/\u0026rdquo;.\nA new munging script, \u0026ldquo;7_tissue-specific-genes.R\u0026rdquo;, was created and contained the same data preparation steps.\nThe raw data tables were put on the ignore list because:\n they have a header that must be skipped they are not used for any other analysis  The TCGA and MMRF gene expression data was also moved to \u0026ldquo;data\u0026rdquo; in a subdirectory called \u0026ldquo;data/tcga/\u0026rdquo;. This was added to the ignore list for data.\nThe munging begins by organizing the GTEx, HPA, and TCGA data. The MMRF data uses Ensembl gene IDs, so org.Hs.eg.db from Bioconductor was used to get the mappings to Hugo symbols. The following was run to create a data frame mapping the Ensembl gene IDs to their Hugo symbols. It is not included in a munging script because I do not want all of the horrible Bioconductor nonsense in my Namespace.\ncache(\u0026quot;gene_name_tib\u0026quot;, { suppressPackageStartupMessages(library(org.Hs.eg.db)) gene_name_tib \u0026lt;- full_join( as_tibble(as.data.frame(org.Hs.egENSEMBL)), as_tibble(as.data.frame(org.Hs.egSYMBOL)), by = \u0026quot;gene_id\u0026quot; ) %\u0026gt;% dplyr::select(-gene_id) %\u0026gt;% filter(!is.na(ensembl_id) \u0026amp; !is.na(symbol)) return(gene_name_tib) }) gene_name_tib #\u0026gt; # A tibble: 30,903 x 2 #\u0026gt; ensembl_id symbol #\u0026gt; \u0026lt;chr\u0026gt; \u0026lt;chr\u0026gt; #\u0026gt; 1 ENSG00000121410 A1BG #\u0026gt; 2 ENSG00000175899 A2M #\u0026gt; 3 ENSG00000256069 A2MP1 #\u0026gt; 4 ENSG00000171428 NAT1 #\u0026gt; 5 ENSG00000156006 NAT2 #\u0026gt; 6 ENSG00000196136 SERPINA3 #\u0026gt; 7 ENSG00000114771 AADAC #\u0026gt; 8 ENSG00000127837 AAMP #\u0026gt; 9 ENSG00000129673 AANAT #\u0026gt; 10 ENSG00000090861 AARS #\u0026gt; #  with 30,893 more rows  TODO  I need to finish make the list of genes to ignore for each caner cache this list do some plotting of the genes  ","date":1569974400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1569974400,"objectID":"0a181aa613488daf123a69240fc5cb61","permalink":"https://project-notebook-comutation.netlify.com/post/2019-10-02/","publishdate":"2019-10-02T00:00:00Z","relpermalink":"/post/2019-10-02/","section":"post","summary":"Analysis to remove genes that can confidently be removed This was originally done in the old analysis structure, so can mainly be copied over to this directory system.\nThe HPA and GTEx data were moved from \u0026ldquo;/n/no_backup2/dbmi/park/jc604/databases/tissue_gene_expression/\u0026rdquo; to \u0026ldquo;data/tissue-gene-expression/\u0026rdquo;.\nA new munging script, \u0026ldquo;7_tissue-specific-genes.R\u0026rdquo;, was created and contained the same data preparation steps.\nThe raw data tables were put on the ignore list because:\n they have a header that must be skipped they are not used for any other analysis  The TCGA and MMRF gene expression data was also moved to \u0026ldquo;data\u0026rdquo; in a subdirectory called \u0026ldquo;data/tcga/\u0026rdquo;.","tags":[],"title":"2019-10-02","type":"post"},{"authors":[],"categories":[],"content":" Munging DepMap 2019 Q3 release (cont.) Sample Info Information about all of the cell lines is available in \u0026ldquo;data/depmap19Q3/sample_info.csv\u0026rdquo;. I added a column \u0026quot;cancer\u0026quot; with the TCGA cancer names for each cell line; a NA value means it isn\u0026rsquo;t used in this project. I also joined kras_mutation_tib. Note, that this will duplicate any rows with multiple KRAS mutations.\nGene Effect This is the data for the effect of knocking out a gene. The tall-format tibble was saved to gene_effect.\nGene Dependency This is the data for the probability that a cell line is dependent upon the target gene. The tall-format tibble was saved to dependency_prob.\nRNAi KH has indicated some interest in using the RNAi experimental data, too.\nThe data was obtained from DepMap.\nwget -O data/depmap19Q3/D2_combined_gene_dep_scores.csv https://ndownloader.figshare.com/files/13515395  The tall-format tibble was saved to rnai_effect.\nPreparing data for modeling A new munging script was created to create the input data for the modeling of depletion effect by KRAS allele: \u0026ldquo;munge/15_depmap19Q3_model-data-prep.R\u0026rdquo;.\nThe first step was to identify the cell lines with multiple oncogenic KRAS mutations. They cannot be used for the analysis.\nCell lines with a BRAF V600E or oncogenic NRAS mutation will be removed, too.\nA base data frame was created for the modeling data. Only the cell lines for the relevant cancers were kept. It has the KRAS mutation information for each cell line and two columns for whether the gene is noted as essential or nonessential by DepMap (NA if neither). This data frame was cached as \u0026ldquo;model_data_base\u0026rdquo;.\nOnly alleles with at least 3 cell lines can be considered for this analysis. Another data frame was created to reflect this.\n734 genes for 3 cell lines were NA in the raw data. The cell lines were ACH-000118 (PAAD, KRAS G12R) ACH-000658 (MM, KRAS WT) ACH-001061 (COAD, KRAS WT). These data points were removed.\nNot all genes will be tested in the analysis because they do not exhibit a strong enough of a lethal effect. There were two criteria:\n a manual threshold of causing a depletion effect of -0.2 in at least two cell lines a metric based on a comparison of the scores in essential and non-essential genes  The threshold for the first criteria was two standard deviations above the mean of essential genes. The threshold for the second criteria was at the point where the distributions of the depletion effects of the essential and nonessential genes overlapped. By eye, these two cut-offs were fairly similar for each cancer. I should do an analysis of the effect of various cut-offs for the number of genes (added to TODO/Analyses/)\nRNA expression for each gene of each cell line was added as another column to the model data frame.\nAnother column was added to the model data frame called \u0026quot;is_altered\u0026quot;. It is true if there is a CNA or coding mutation in the cell line\u0026rsquo;s gene (else false).\nThis final data frame was saved as model_data_base where \u0026ldquo;base\u0026rdquo; denotes that it has all of the data to use for all of the models.\nAnother data frame was built from model_data_base that only has the data for KRAS alleles (including WT) that have at least 3 cell lines. This was cached as model_data.\nTODO I have forgotten to include the list of genes that can confidently be ignored from analysis for each cancer. I need to integrate these data in, too.\n","date":1569801600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1569844336,"objectID":"a061ab55829dff5ad52d57800500aa6f","permalink":"https://project-notebook-comutation.netlify.com/post/2019-09-30/","publishdate":"2019-09-30T00:00:00Z","relpermalink":"/post/2019-09-30/","section":"post","summary":"Munging DepMap 2019 Q3 release (cont.) Sample Info Information about all of the cell lines is available in \u0026ldquo;data/depmap19Q3/sample_info.csv\u0026rdquo;. I added a column \u0026quot;cancer\u0026quot; with the TCGA cancer names for each cell line; a NA value means it isn\u0026rsquo;t used in this project. I also joined kras_mutation_tib. Note, that this will duplicate any rows with multiple KRAS mutations.\nGene Effect This is the data for the effect of knocking out a gene.","tags":[],"title":"2019-09-30","type":"post"},{"authors":[],"categories":[],"content":" I am beginning the migration process from the only comutation directory to this project.\nDownloading DepMap 2019 Q3 release The first step is moving over the raw data into the new data directory. DepMap release 19Q3 data, so the new data sets were downloaded into \u0026ldquo;data/depmap19Q3/\u0026rdquo;\nwget -O Achilles_gene_effect.csv https://ndownloader.figshare.com/files/16757666 wget -O Achilles_gene_dependency.csv https://ndownloader.figshare.com/files/16757660 wget -O Achilles_guide_efficacy.csv https://ndownloader.figshare.com/files/16757669 wget -O Achilles_common_essentials.csv https://ndownloader.figshare.com/files/16757654 wget -O common_essentials.csv https://ndownloader.figshare.com/files/16757714 wget -O nonessentials.csv https://ndownloader.figshare.com/files/16757717 wget -O Achilles_guide_map.csv https://ndownloader.figshare.com/files/16757672 wget -O CCLE_expression.csv https://ndownloader.figshare.com/files/16757690 wget -O CCLE_gene_cn.csv https://ndownloader.figshare.com/files/16757699 wget -O CCLE_fusions.csv https://ndownloader.figshare.com/files/16757696 wget -O CCLE_mutations.csv https://ndownloader.figshare.com/files/16757702 wget -O sample_info.csv https://ndownloader.figshare.com/files/16757723  Munging DepMap 2019 Q3 release I then created the munging script called \u0026ldquo;10_depmap19Q3.R\u0026rdquo; to prepare the data downloaded from DepMap.\nEssentiality A single data frame was created for all of the data concerning whether a gene is labeled essential or non-essential. To help, I created get_huo_from_depmap_ids() and get_entrez_from_depmap_ids() to extract the appropriate names from the data tables. These functions are in \u0026ldquo;libs/helpers.R\u0026rdquo;. Tests were written in \u0026ldquo;tests/test-helpers.R\u0026rdquo;.\nCopy Number A data frame of CNA was created ccle_copy_number. According to the README from DepMap, the copy number values were \u0026ldquo;Gene level copy number data, log2 transformed with a pseudo count of 1.\u0026rdquo; However, looking at the values when converted back ($2^{x}$), I do not think there is a pseudo count because most of the values are 1 is there was. Therefore, I did not subtract 1 from the conversion. I also added a label for homozygous deletion (\u0026ldquo;homo_del\u0026rdquo;), heterozygous deletion (\u0026ldquo;het_del\u0026rdquo;), amplification (\u0026ldquo;amp\u0026rdquo;), or no change (\u0026ldquo;norm\u0026rdquo;).\nMutations The CCLE mutations were tidied up, though not much was needed. I cached two data frames: ccle_mutations has all of the mutations, and ccle_mutations_coding has only coding mutations.\nRNA Expression The RNA expression data is described by DepMap as follows:\n RNAseq TPM gene expression data for just protein coding genes using RSEM. Log2 transformed, using a pseudo-count of 1.\n The tall formatted data was cached as ccle_expression.\nKRAS mutants A tibble was made to hold the mutation information KRAS. This included coding mutations and copy number amplifications.\nTODO  Finish munging the new DepMap data.  ","date":1569628800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1569698885,"objectID":"5e30cd0a55835c8ebbde0a91b3c91eaf","permalink":"https://project-notebook-comutation.netlify.com/post/2019-09-28/","publishdate":"2019-09-28T00:00:00Z","relpermalink":"/post/2019-09-28/","section":"post","summary":"I am beginning the migration process from the only comutation directory to this project.\nDownloading DepMap 2019 Q3 release The first step is moving over the raw data into the new data directory. DepMap release 19Q3 data, so the new data sets were downloaded into \u0026ldquo;data/depmap19Q3/\u0026rdquo;\nwget -O Achilles_gene_effect.csv https://ndownloader.figshare.com/files/16757666 wget -O Achilles_gene_dependency.csv https://ndownloader.figshare.com/files/16757660 wget -O Achilles_guide_efficacy.csv https://ndownloader.figshare.com/files/16757669 wget -O Achilles_common_essentials.csv https://ndownloader.figshare.com/files/16757654 wget -O common_essentials.csv https://ndownloader.figshare.com/files/16757714 wget -O nonessentials.csv https://ndownloader.","tags":[],"title":"2019-09-28","type":"post"},{"authors":[],"categories":[],"content":"I have used the \u0026lsquo;ProjectTemplate\u0026rsquo; R package to build the framework for the analysis. I created a lab notebook in reports using the \u0026lsquo;blogdown\u0026rsquo; package which serves the site to the \u0026lsquo;docs/\u0026rsquo; directory.\nThe remote repository is hosted by GitHub at jhrcook/comutation and is private. The lab notebook is hosted by Netlify and is located at project-notebook-comutation.netlify.com. It is open to the public, but is not easily found.\nI have trimmed down the default academic hugo theme to only include the sections About, Posts, and Contact.\n","date":1569283200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1569358927,"objectID":"8dad289a593761b7140ccde512194e26","permalink":"https://project-notebook-comutation.netlify.com/post/new-project-structure/","publishdate":"2019-09-24T00:00:00Z","relpermalink":"/post/new-project-structure/","section":"post","summary":"I have used the \u0026lsquo;ProjectTemplate\u0026rsquo; R package to build the framework for the analysis. I created a lab notebook in reports using the \u0026lsquo;blogdown\u0026rsquo; package which serves the site to the \u0026lsquo;docs/\u0026rsquo; directory.\nThe remote repository is hosted by GitHub at jhrcook/comutation and is private. The lab notebook is hosted by Netlify and is located at project-notebook-comutation.netlify.com. It is open to the public, but is not easily found.\nI have trimmed down the default academic hugo theme to only include the sections About, Posts, and Contact.","tags":[],"title":"2019-09-24 - New project structure","type":"post"},{"authors":["Comutation of KRAS"],"categories":null,"content":" Click the Slides button above to demo Academic\u0026rsquo;s Markdown slides feature.   Supplementary notes can be added here, including code and math.\n","date":1554595200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1554595200,"objectID":"557dc08fd4b672a0c08e0a8cf0c9ff7d","permalink":"https://project-notebook-comutation.netlify.com/publication/preprint/","publishdate":"2017-01-01T00:00:00Z","relpermalink":"/publication/preprint/","section":"publication","summary":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum.","tags":["Source Themes"],"title":"An example preprint / working paper","type":"publication"},{"authors":[],"categories":[],"content":" Welcome to Slides Academic\nFeatures  Efficiently write slides in Markdown 3-in-1: Create, Present, and Publish your slides Supports speaker notes Mobile friendly slides  Controls  Next: Right Arrow or Space Previous: Left Arrow Start: Home Finish: End Overview: Esc Speaker notes: S Fullscreen: F Zoom: Alt + Click PDF Export: E  Code Highlighting Inline code: variable\nCode block:\nporridge = \u0026quot;blueberry\u0026quot; if porridge == \u0026quot;blueberry\u0026quot;: print(\u0026quot;Eating...\u0026quot;)  Math In-line math: $x + y = z$\nBlock math:\n$$ f\\left( x \\right) = \\;\\frac{{2\\left( {x + 4} \\right)\\left( {x - 4} \\right)}}{{\\left( {x + 4} \\right)\\left( {x + 1} \\right)}} $$\nFragments Make content appear incrementally\n{{% fragment %}} One {{% /fragment %}} {{% fragment %}} **Two** {{% /fragment %}} {{% fragment %}} Three {{% /fragment %}}  Press Space to play!\nOne  Two  Three \nA fragment can accept two optional parameters:\n class: use a custom style (requires definition in custom CSS) weight: sets the order in which a fragment appears  Speaker Notes Add speaker notes to your presentation\n{{% speaker_note %}} - Only the speaker can read these notes - Press `S` key to view {{% /speaker_note %}}  Press the S key to view the speaker notes!\n Only the speaker can read these notes Press S key to view   Themes  black: Black background, white text, blue links (default) white: White background, black text, blue links league: Gray background, white text, blue links beige: Beige background, dark text, brown links sky: Blue background, thin dark text, blue links   night: Black background, thick white text, orange links serif: Cappuccino background, gray text, brown links simple: White background, black text, blue links solarized: Cream-colored background, dark green text, blue links  Custom Slide Customize the slide style and background\n{{\u0026lt; slide background-image=\u0026quot;/img/boards.jpg\u0026quot; \u0026gt;}} {{\u0026lt; slide background-color=\u0026quot;#0000FF\u0026quot; \u0026gt;}} {{\u0026lt; slide class=\u0026quot;my-style\u0026quot; \u0026gt;}}  Custom CSS Example Let\u0026rsquo;s make headers navy colored.\nCreate assets/css/reveal_custom.css with:\n.reveal section h1, .reveal section h2, .reveal section h3 { color: navy; }  Questions? Ask\nDocumentation\n","date":1549324800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1549324800,"objectID":"0e6de1a61aa83269ff13324f3167c1a9","permalink":"https://project-notebook-comutation.netlify.com/slides/example/","publishdate":"2019-02-05T00:00:00Z","relpermalink":"/slides/example/","section":"slides","summary":"An introduction to using Academic's Slides feature.","tags":[],"title":"Slides","type":"slides"},{"authors":["Comutation of KRAS","Robert Ford"],"categories":null,"content":" Click the Cite button above to demo the feature to enable visitors to import publication metadata into their reference management software.    Click the Slides button above to demo Academic\u0026rsquo;s Markdown slides feature.   Supplementary notes can be added here, including code and math.\n","date":1441065600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1441065600,"objectID":"966884cc0d8ac9e31fab966c4534e973","permalink":"https://project-notebook-comutation.netlify.com/publication/journal-article/","publishdate":"2017-01-01T00:00:00Z","relpermalink":"/publication/journal-article/","section":"publication","summary":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum.","tags":["Source Themes"],"title":"An example journal article","type":"publication"},{"authors":["Comutation of KRAS","Robert Ford"],"categories":null,"content":" Click the Cite button above to demo the feature to enable visitors to import publication metadata into their reference management software.    Click the Slides button above to demo Academic\u0026rsquo;s Markdown slides feature.   Supplementary notes can be added here, including code and math.\n","date":1372636800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1372636800,"objectID":"69425fb10d4db090cfbd46854715582c","permalink":"https://project-notebook-comutation.netlify.com/publication/conference-paper/","publishdate":"2017-01-01T00:00:00Z","relpermalink":"/publication/conference-paper/","section":"publication","summary":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum.","tags":["Source Themes"],"title":"An example conference paper","type":"publication"}]